Greenleaf Trust Raises Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Greenleaf Trust lifted its holdings in The Procter & Gamble Company (NYSE:PG) by 0.2% in the third quarter, HoldingsChannel reports. The firm owned 106,645 shares of the company’s stock after purchasing an additional 243 shares during the quarter. Greenleaf Trust’s holdings in Procter & Gamble were worth $18,471,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Steele Capital Management Inc. purchased a new stake in shares of Procter & Gamble during the 1st quarter valued at about $204,000. GAMMA Investing LLC raised its position in Procter & Gamble by 67.2% during the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares during the period. Consilio Wealth Advisors LLC lifted its stake in shares of Procter & Gamble by 27.7% in the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after purchasing an additional 379 shares during the last quarter. AMF Tjanstepension AB boosted its holdings in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the period. Finally, Talbot Financial LLC increased its position in shares of Procter & Gamble by 1.5% during the 1st quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock valued at $10,644,000 after purchasing an additional 950 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the sale, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. Insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Up 0.0 %

Shares of Procter & Gamble stock traded up $0.03 on Wednesday, reaching $169.73. The stock had a trading volume of 259,717 shares, compared to its average volume of 6,659,746. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $400.59 billion, a P/E ratio of 29.26, a P/E/G ratio of 3.72 and a beta of 0.41. The company has a 50 day moving average price of $171.87 and a 200 day moving average price of $167.43. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the company earned $1.83 earnings per share. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.37%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. DA Davidson raised their price target on Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research report on Monday. JPMorgan Chase & Co. lifted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Stifel Nicolaus increased their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Deutsche Bank Aktiengesellschaft boosted their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research note on Thursday, August 29th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.